Product Development
Next-generation DNA damage response programs at AACR

Clinical readouts for WEE1 inhibitors, next-generation compounds against PARP and a pair of agents targeting CDC7 were among the DNA damage response programs featured at AACR this year.

Downsized FerGene gains FDA extension to resubmit gene therapy, resolve CMC issues

A year after Blackstone-backed Ferring subsidiary FerGene received a complete response letter for its gene therapy for bladder cancer, investors in the downsized biotech remain committed to the ...

April 14 Quick Takes: GSK stops two trials of ICOS agonist; plus Trodelvy, Amylyx, Junshi, Jazz, MitoChem

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it is discontinuing treatment with ICOS agonist feladilimab (GSK3359609) in two Phase II trials for metastatic head and neck squamous cell carcinoma ...

Politics, Policy & Law
Georgia biotech leaders support voting rights, resist calls to shun their state

Biotech industry leaders in Georgia, ground zero for the voting rights controversy, expressed solidarity with the ideas expressed in a letter signed by biotech leaders supporting voting rights, but ...

Tango is latest target in string of biotech SPAC mergers: Data Byte

Tango raised more than $350 million in a SPAC deal that brings the total number of biotech SPAC mergers to at least 21. The synthetic lethality company said on Wednesday it is merging with BCTG ...

Management Tracks
Management shuffle at Novavax; plus Skyhawk, Kyverna, Gemini and more

Greg Covino will step down as CFO and become executive adviser to Novavax Inc. (NASDAQ:NVAX). The vaccine developer hired Troy Morgan as SVP and chief compliance officer and promoted Gale Smith to SVP ...

BioCentury ISSN 1097-7201